Literature DB >> 18269639

Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.

M R Cunha1, M E R Silva, H A Machado, R T Fukui, M R S Correia, R F Santos, B L Wajchenberg, D M Rocha, M U P B Rondon, C E Negrão, M J M Ursich.   

Abstract

OBJECTIVES: To evaluate the effects of Metformin and Glyburide on cardiovascular, metabolic and hormonal parameters during progressive exercise performed to exhaustion in the post-prandial state in women with type 2 diabetes (T2DM). DESIGN AND METHODS: Ten T2DM patients treated with Metformin (M group), 10 with Glyburide (G group) and 10 age-paired healthy subjects exercised on a bicycle ergometer up to exercise peak. Cardiovascular and blood metabolic and hormonal parameters were measured at times -60 min, 0 min, exercise end, and at 10 and 20 minutes of recovery phase. Thirty minutes before the exercise, a standard breakfast was provided to all participants. The diabetic patients took Metformin or Glyburide before or with meal.
RESULTS: Peak oxygen uptake (VO(2)) was lower in patients with diabetes. Plasma glucose levels remained unchanged, but were higher in both diabetic groups. Patients with diabetes also presented lower insulin levels after meals and higher glucagon levels at exercise peak than C group. Serum cortisol levels were higher in G than M group at exercise end and recovery phase. Lactate levels were higher in M than G group at fasting and in C group at exercise peak. Nor epinephrine, GH and FFA responses were similar in all 3 groups.
CONCLUSION: Progressive exercise performed to exhaustion, in the post-prandial state did not worsen glucose control during and after exercise. The administration of the usual dose of Glyburide or Metformin to T2DM patients did not influence the cardiovascular, metabolic and hormonal response to exercise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269639     DOI: 10.1111/j.1463-1326.2006.00690.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  5 in total

1.  Acute inhibition of ATP-sensitive K+ channels impairs skeletal muscle vascular control in rats during treadmill exercise.

Authors:  Clark T Holdsworth; Steven W Copp; Scott K Ferguson; Gabrielle E Sims; David C Poole; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-27       Impact factor: 4.733

Review 2.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

3.  Metformin and exercise in type 2 diabetes: examining treatment modality interactions.

Authors:  Normand G Boulé; Cheri Robert; Gordon J Bell; Steven T Johnson; Rhonda C Bell; Richard Z Lewanczuk; Raniah Q Gabr; Dion R Brocks
Journal:  Diabetes Care       Date:  2011-05-20       Impact factor: 19.112

4.  Effects of the combination of metformin and exercise on glycated hemoglobin, functional capacity, lipid profile, quality of life, and body weight.

Authors:  Sherif Eltonsy; Monique Dufour Doiron; Patrice Simard; Caroline Jose; Martin Sénéchal; Danielle R Bouchard; Rémi LeBlanc; Mathieu Bélanger
Journal:  J Int Med Res       Date:  2019-01-07       Impact factor: 1.671

5.  Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial.

Authors:  Jonas M Kristensen; Christian Lillelund; Rasmus Kjøbsted; Jesper B Birk; Nicoline R Andersen; Lars Nybo; Karin Mellberg; Anudharan Balendran; Erik A Richter; Jørgen F P Wojtaszewski
Journal:  Physiol Rep       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.